THEMISMED.BOTHEMISMED.BOBSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR-44.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-44.8%/yr
vs +61.3%/yr prior
Acceleration
-106.1pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 3.22% |
| 2024 | 1.53% |
| 2023 | 24.46% |
| 2022 | 19.15% |
| 2021 | 147.57% |
| 2020 | -25.14% |
| 2019 | -13.23% |
| 2018 | 2.83% |
| 2017 | 46.58% |
| 2016 | 31.60% |